Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC

Stopped New studies available with immunotherapy so recruitment is no longer acceptable.

Conditions

• Non-Small Cell Lung Cancer

Interventions

• DRUG: Cisplatin
• RADIATION: hypofractionated radiotherapy
• DRUG: Pemetrexed
• DRUG: Etoposide

Sponsor

The Netherlands Cancer Institute